Skip to main content
. 2017 Jan 10;12(1):e0169714. doi: 10.1371/journal.pone.0169714

Fig 6. Blocking CCL5-CCR5 interaction with siRNA (original magnification ×200).

Fig 6

(A) In trans-well migration assays (n = 3 for each group), treatment of CCR5 siRNAs effectively abrogates the enhanced migration of MMD SPCs by the presence of MMD ECFCs or addition of rhCCL5. (B) Quantification of migrated cells.